Search Within

Shari Goldfarb

  1. "Larry Norton"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  2. Breast Medicine Service (17)
  3. Department of Medicine (17)
  4. Epidemiology and Biostatistics (17)
  5. Health Outcomes Research Group (17)
  6. Population Sciences Research Program (17)

More Groups

People
  1. Larry Norton (17)
  2. Clifford Hudis (14)
  3. Shanu Modi (13)
  4. Diana Lake (12)
  5. Chau Dang (11)
  6. Maura Dickler (11)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (3)
  4. 2016 (3)
  5. 2015 (3)
  6. 2014 (1)

More Years

Publications
  1. Cancer Research (7)
  2. Journal of Clinical Oncology (4)
  3. Annals of Oncology (2)
  4. Breast Cancer Research and Treatment (1)
  5. Clinical Breast Cancer (1)
  6. JAMA Dermatology (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (4)
  3. American Medical Association (2)
  4. Oxford University Press (2)
  5. Elsevier Inc. (1)
  6. Springer (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Objective and subjective vulvovaginal symptoms in breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Saban, S.; Arkema, A.; Patil, S.; Flynn, J.; Goldfrank, D. J.; Norton, L.; Carter, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia
    Journal Article

    Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
    Journal Article

    Belum, V. R.; Silva, G. D.; Laloni, M. T.; Ciccolini, K.; Goldfarb, S. B.; Norton, L.; Sklarin, N. T.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save